@prefix this: . @prefix sub: . @prefix schema: . @prefix np: . @prefix dct: . @prefix nt: . @prefix xsd: . @prefix orcid: . @prefix nkg: . @prefix prov: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { schema:possibleTreatment sub:medtherapy . sub:medtherapy prov:wasDerivedFrom sub:quote; schema:drug ; schema:targetPopulation sub:targetpop; nkg:indicationType schema:TreatmentIndication . sub:quote prov:value "Divalproex sodium delayed-release capsules are indicated as monotherapy and adjunctive therapy in the treatment of adult patients and pediatric patients down to the age of 10 years with complex partial seizures that occur either in isolation or in association with other types of seizures."; prov:wasQuotedFrom . } sub:provenance { sub:assertion prov:wasAttributedTo orcid:0000-0002-1468-3557 . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB"; npx:hasSignature "By4qsrYd/1yHDA/xapWHA7s3qMiMUtNefp7Vjeo8XHRD/jBgOHt9dy3+bP09Mdz6U5fPAP/9gdj/amKz1lw7559DP6JRtV6ywx7Z1rf7IY/b+u0eIZuouh0ewGfKnbPyoQWEMmhY63tkT8QS7YsUACHqUKH96VTAsdQ3+l+dXvE="; npx:hasSignatureTarget this: . this: dct:created "2021-04-03T11:07:24.450+02:00"^^xsd:dateTime; dct:creator orcid:0000-0002-1468-3557; nt:wasCreatedFromProvenanceTemplate ; nt:wasCreatedFromPubinfoTemplate ; nt:wasCreatedFromTemplate . }